Seattle Sperm Bank – FDA 483, Jun 19, 2026

Seattle Sperm Bank in Las Vegas, NV, was cited for deficiencies in its donor screening and eligibility procedures during an FDA inspection. The firm failed to adequately screen HCT/P donors for communicable disease risks and lacked proper instructions in its standard operating procedures for determining donor eligibility. These issues indicate a moderate level of concern regarding donor safety and compliance with regulatory requirements.